Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

ADAM10 regulates transcription factor expression required for plasma cell function.

Chaimowitz NS, Kang DJ, Dean LM, Conrad DH.

PLoS One. 2012;7(8):e42694. doi: 10.1371/journal.pone.0042694. Epub 2012 Aug 3.

2.

Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.

Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T, Ludwig T, Rajewsky K, Dalla-Favera R.

Nat Immunol. 2006 Jul;7(7):773-82. Epub 2006 Jun 11.

PMID:
16767092
3.

Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.

Reinhardt S, Schuck F, Grösgen S, Riemenschneider M, Hartmann T, Postina R, Grimm M, Endres K.

FASEB J. 2014 Feb;28(2):978-97. doi: 10.1096/fj.13-234864. Epub 2013 Oct 28.

4.

A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture.

Chaimowitz NS, Martin RK, Cichy J, Gibb DR, Patil P, Kang DJ, Farnsworth J, Butcher EC, McCright B, Conrad DH.

J Immunol. 2011 Nov 15;187(10):5114-22. doi: 10.4049/jimmunol.1102172. Epub 2011 Oct 12.

5.

Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.

Ochiai K, Maienschein-Cline M, Simonetti G, Chen J, Rosenthal R, Brink R, Chong AS, Klein U, Dinner AR, Singh H, Sciammas R.

Immunity. 2013 May 23;38(5):918-29. doi: 10.1016/j.immuni.2013.04.009. Epub 2013 May 16.

6.

Disturbed follicular architecture in B cell A disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding.

Folgosa L, Zellner HB, El Shikh ME, Conrad DH.

J Immunol. 2013 Dec 15;191(12):5951-8. doi: 10.4049/jimmunol.1302042. Epub 2013 Nov 13.

7.

IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.

Teng Y, Takahashi Y, Yamada M, Kurosu T, Koyama T, Miura O, Miki T.

Eur J Cell Biol. 2007 Oct;86(10):581-9. Epub 2007 Jul 24.

PMID:
17651861
8.

Adam10 mediates the choice between principal cells and intercalated cells in the kidney.

Guo Q, Wang Y, Tripathi P, Manda KR, Mukherjee M, Chaklader M, Austin PF, Surendran K, Chen F.

J Am Soc Nephrol. 2015 Jan;26(1):149-59. doi: 10.1681/ASN.2013070764. Epub 2014 Jun 5.

9.

The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity.

Gibb DR, Saleem SJ, Chaimowitz NS, Mathews J, Conrad DH.

Mol Immunol. 2011 Jun;48(11):1319-27. doi: 10.1016/j.molimm.2010.12.005. Epub 2011 Jan 13. Review.

10.

ADAM10 regulates Notch function in intestinal stem cells of mice.

Tsai YH, VanDussen KL, Sawey ET, Wade AW, Kasper C, Rakshit S, Bhatt RG, Stoeck A, Maillard I, Crawford HC, Samuelson LC, Dempsey PJ.

Gastroenterology. 2014 Oct;147(4):822-834.e13. doi: 10.1053/j.gastro.2014.07.003. Epub 2014 Jul 16.

11.

Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance.

Cattoretti G, Shaknovich R, Smith PM, Jäck HM, Murty VV, Alobeid B.

J Immunol. 2006 Nov 15;177(10):6930-9.

12.

The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.

Doberstein K, Pfeilschifter J, Gutwein P.

Carcinogenesis. 2011 Nov;32(11):1713-23. doi: 10.1093/carcin/bgr195. Epub 2011 Aug 30.

PMID:
21880579
13.

ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.

Caolo V, Swennen G, Chalaris A, Wagenaar A, Verbruggen S, Rose-John S, Molin DG, Vooijs M, Post MJ.

Angiogenesis. 2015 Jan;18(1):13-22. doi: 10.1007/s10456-014-9443-4. Epub 2014 Sep 14.

PMID:
25218057
14.

Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS.

Qi CF, Jessberger R, Torrey TA, Taddesse-Heath L, Ohta Y, Morse HC 3rd.

Mol Immunol. 1999 Oct-Nov;36(15-16):1043-53.

PMID:
10698307
15.

The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice.

Kitaoka K, Shimizu N, Ono K, Chikahisa S, Nakagomi M, Shudo K, Ishimura K, Séi H, Yoshizaki K.

Neuropharmacology. 2013 Sep;72:58-65. doi: 10.1016/j.neuropharm.2013.04.009. Epub 2013 Apr 23.

PMID:
23624141
16.

Adam10 is essential for early embryonic cardiovascular development.

Zhang C, Tian L, Chi C, Wu X, Yang X, Han M, Xu T, Zhuang Y, Deng K.

Dev Dyn. 2010 Oct;239(10):2594-602. doi: 10.1002/dvdy.22391.

17.

Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosis.

van der Vorst EP, Jeurissen M, Wolfs IM, Keijbeck A, Theodorou K, Wijnands E, Schurgers L, Weber S, Gijbels MJ, Hamers AA, Dreymueller D, Rose-John S, de Winther MP, Ludwig A, Saftig P, Biessen EA, Donners MM.

Am J Pathol. 2015 Apr;185(4):1145-55. doi: 10.1016/j.ajpath.2014.11.028. Epub 2015 Feb 7.

PMID:
25659879
18.

The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling.

Weber S, Niessen MT, Prox J, Lüllmann-Rauch R, Schmitz A, Schwanbeck R, Blobel CP, Jorissen E, de Strooper B, Niessen CM, Saftig P.

Development. 2011 Feb;138(3):495-505. doi: 10.1242/dev.055210.

19.

ADAM10 negatively regulates neuronal differentiation during spinal cord development.

Yan X, Lin J, Talabattula VA, Mußmann C, Yang F, Wree A, Rolfs A, Luo J.

PLoS One. 2014 Jan 3;9(1):e84617. doi: 10.1371/journal.pone.0084617. eCollection 2014.

20.

Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.

Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM.

J Biol Chem. 2009 Aug 21;284(34):22590-600. doi: 10.1074/jbc.M109.032599. Epub 2009 Jun 29.

Supplemental Content

Support Center